Q. Li

机构：University of Electronic Science and Technology of China, Fosun Pharma (China), S.P.E.C.I.E.S. · ORCID：0000-0003-4436-1169

发表论文 20 篇 · 总被引 205 次 · h-index 6

代表论文

• The Ankylosing Spondylitis Disease Activity Score is a highly discriminatory measure of disease activity and efficacy following tumour necrosis factor-  inhibitor therapies in ankylosing spondylitis and undifferentiated spondyloarthropathies in China (2011 · Lara D. Veeken · 被引 43)
• HLA‐B27 polymorphism in patients with juvenile and adult‐onset ankylosing spondylitis in Southern China (2009 · Tissue Antigens · 被引 38)
• Epidemiological comparison of clinical manifestations according to HLA ‐B*27 carrier status of Chinese Ankylosing Spondylitis patients (2013 · Tissue Antigens · 被引 34)
• Higher risk of uveitis and dactylitis and older age of onset among ankylosing spondylitis patients with HLA ‐B*2705 than patients with HLA ‐B*2704 in the Chinese population (2013 · Tissue Antigens · 被引 27)
• Association of triglyceride-glucose index and its combination with adiposity-related indices with the incidence of myocardial infarction: a cohort study from the UK Biobank (2024 · International Journal of Obesity · 被引 17)
• Unlocking Green Biomanufacturing Potential: Superior Heterologous Gene Expression with a T7 Integration Overexpression System in Bacillus subtilis (2024 · ACS Synthetic Biology · 被引 6)